Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts

Labcorp Holdings Inc. upgraded to Buy: resilient diagnostics demand, strong Q2, modest valuation and new tests offset Medicare cuts. Click for this LH update.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha